Undiagnosed, untreated blood disorders in women and young girls have medical consequences and unique issues at every life stage, creating the need for a foundation dedicated to education and awareness.
We work to achieve this goal by raising awareness and educating the key healthcare providers for each particular life stage and translating and disseminating provider information and research.
The Foundation for Women & Girls with Blood Disorders Research Awards provide financial support for qualified fellows or junior attending/junior faculty pursuing clinical, t…
Dr. Barbara Konkle, one of FWGBD's founding members, has been recognized by the International Society on Thrombosis and Hemostasis (ISTH) with its 2021 Esteemed Career Award.
Please join the CDC's Division of Blood Disorders and featured presenter Dr. Alexis Thompson for a webinar on BMT and other curative approaches to thalassemia on June 24, 2021, from 2:00-3:00 pm ET.
Join The RUNX1 Research Program (RRP), the Platelet Disorder Support Association (PDSA), and FWGBD for a Webinar on inherited platelet disorders on June 28 from 11 am -12 pm EST.
The World Federation on Hemophilia will be hosting its Global Summit on Women & Girls with Bleeding Disorders from July 8-10, 2021.
Please plan to join ISTH on June 1st, 2021, from 09:30 - 10:30 EST, for a webinar on how COVID-19 has brought challenges for hemostasis and thrombosis care.
The Foundation for Women & Girls with Blood Disorders is proud to announce the recent appointment of its newest board members, Sarah O’Brien, MD, MSc and Jeffrey H. Lawson, MD, PhD.
The Anticoagulation Forum has issued new interim clinical guidance on thromboembolism and anticoagulant therapy during the COVID-19.
ISTH has issued interim guidance for the diagnosis and treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT) and is designed to inform the management of suspected thrombosis in subjects who have recently received the AstraZeneca or Johnson & Johnson vaccines.
Please join NHF for its April Webinar Series on Wednesdays from 2-3 pm ET on a range of topics of interest to the blood disorder community.
